Researchers have developed a single genomic test capable of detecting most neurological and respiratory infectious pathogens in the human body. While the test has the potential to identify all infectious pathogens, its use has so far been limited to neurological and respiratory infections.
The test has shown an 86 percent success rate in diagnosing neurological infections, according to a decade-long study at the University of California–San Francisco (UCSF), published on Nov. 12 in Nature Medicine.
